siRNA customization has never been easier.

As mentioned earlier, there are few if any reports about cation polymers as carriers for COX-2 siRNA delivery. Here we used PEGylated PEI, a common cationic polymer applied in siRNA transfection [, ] as a control. PEI increased the expression of COX-2 to such an extent that it offset downregulation caused by siRNA. Our degradable compound 4 was cleaved to release amine groups with positive charge. Compared to macromolecules, the small molecules with amine groups were rapidly removed from cells. These detached amine groups were distributed more uniformly in the cytoplasm, which reduced positive charge density. Due to high biocompatibility, although the dextran scaffold was depolymerized to small molecules by α-1-glucosidases present in cells and various organs,[] their retention in cells did not affect COX-2 expression. Consequently, our degradable compound 4 minimized inflammation, and was able to downregulate COX-2 successfully.

Keywords: dextran, COX-2 siRNA therapy, biodegradable polymer, imaging, cancer

The results demonstrate that both siRNA reagents (at 20 nM) decrease the expression of the targeted MAPK14 gene by at least 70 percent. Neither siRNA method affects the expression of GAPD. However, the synthetic siRNA also non-specifically decreases the expression of RRAD and increases the expression of CTGF, even at the lower concentration (5 nM). The enzymatically-generated population does not affect the expression of these genes even at the higher concentration (20 nM). The reproducible results achieved for this single gene support the hypothesis that enzymatically generated siRNA more specifically knocks down the expression of the targeted gene than chemically synthesized siRNA.


Gene Silencing Service and SiRNA Synthesis .

List of siRNA-based drugs targeting different diseases were in clinical trials.

23. Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. 2007;121:64-73


Custom siRNA's according to your specs, or let us …

114. Patil ML, Zhang M, Taratula O, Garbuzenko OB, He H, Minko T. Internally Cationic Polyamidoamine PAMAM-OH Dendrimers for siRNA Delivery: Effect of the Degree of Quaternization and Cancer Targeting. 2009;10:258-266

Dharmacon siRNA Production | Biocompare Product …

113. Patil ML, Zhang M, Minko T. Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing. 2011;5:1877-1887

22/08/2006 · A review of the Dharmacon siRNA ..

112. Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery. 2008;19:1396-1403

Stealth™ RNAi primers or siRNA duplexes for ..

120. Gabrielson NP, Lu H, Yin L, Kim KH, Cheng J. A cell-penetrating helical polymer for siRNA delivery to mammalian cells. 2012;20:1599-1609

Improve Existing Aptamers & siRNA - AMBiotech

106. Zhang LM, Lu ZX, Zhao QH, Huang J, Shen H, Zhang ZJ. Enhanced Chemotherapy Efficacy by Sequential Delivery of siRNA and Anticancer Drugs Using PEI-Grafted Graphene Oxide. 2011;7:460-464

Improve Existing Aptamers & siRNA

96. Podesta JE, Al-Jamal KT, Herrero MA, Tian BW, Ali-Boucetta H, Hegde V. . Antitumor Activity and Prolonged Survival by Carbon-Nanotube-Mediated Therapeutic siRNA Silencing in a Human Lung Xenograft Model. 2009;5:1176-1185